iBio, Inc IBIO – Update
It was just this past Thursday morning that we were mentioning our great success in tracking IBIO to multibag gains, beginning when we first highlighted it as a potential coronavirus play on March 17th. We subsequently observed a low of .76, and as of our followup last week, it had produced an increase of over 400%
That was before yesterday, in which IBIO took the #3 top gainer spot on the NASDAQ, and broke out to yet another impressive new high of 7.43. That extends the gain we’ve seen on this play since our initial alert to a mammoth 878% Even as other stocks representing COVID-19 vaccine candidates have been flagging of late, IBIO has continued its impressive uptrend, and we’re excited to see where it goes from here.
Microsoft Inc. MSFT
One of our options ideas from yesterday morning’s report fared quite well during the session, and based on the way things look in the premarket today, we expect to see further increases in our target contracts.
Those were the MSFT Weekly $205-210 Calls and they got off to a really good start with some solid intraday gains:
MSFT Weekly $205-210 Calls
$205: 6.70-11.30 (+69%)
$207.50: 5.65-10.10 (+79%)
$19: 4.75-8.75 (+84%)
We also want to roll up to include the MSFT Weekly $212.50-215 Calls in our watchlist.
Fresh Options Ideas:
PM Weekly $74.50-76 Calls
LMT Weekly $370-380 Calls
IBM Weekly $130-132 Calls
PLD 08/21 $100-105 Calls
Rising Biosciences, Inc. RBII
Another mention from yesterday morning’s premarket report was RBII, and that too exhibited a very nice move on the day.
We have been bringing some of our focus back to OTC stocks quite a bit more in 2020, and this is another in a growing line of solid calls on that front. The stock traded from a low of .003 mand went on to hit .0068, for an intraday rip of 127%
SBFM, GOVX, TTCM, VRUS, CYDY